Dynatronics Corp. (DYNT) Stock Analysis | Price, Returns, Financials & Key Metrics

Price Point

High/Low

1Day

52 Week

Valuation

Technical

Day's Volume

CASH

679

Shareholding (Mar 2025)

FII

0.00%

Held by 0 FIIs

DII

99.77%

Held by 0 DIIs

Promoter

0.00%

What does Dynatronics Corp. do?

22-Jun-2025

Dynatronics Corporation is a micro-cap manufacturer and distributor of physical medicine products in the Pharmaceuticals & Biotechnology industry, with recent net sales of $6 million and a net profit of -$1 million. The company has a market cap of $0.94 million and a debt equity ratio of 0.25.

Who are in the management team of Dynatronics Corp.?

22-Jun-2025

As of March 2022, the management team of Dynatronics Corp. includes Erin Enright (Independent Chairman), John Krier (CEO and Director), Brian Baker (Director), and several Independent Directors: David Holtz, Scott Klosterman, Brian Larkin, and R. Scott Ward. They guide the company's strategic direction and governance.

Is Dynatronics Corp. technically bullish or bearish?

25-Jun-2025

As of October 1, 2023, there is insufficient technical data for Dynatronics Corp. to determine if it is bullish or bearish.

Is Dynatronics Corp. overvalued or undervalued?

25-Jun-2025

As of October 1, 2023, Dynatronics Corp. is considered an attractive investment due to its undervalued financial metrics, including a P/E ratio of 12.5 and a P/B ratio of 1.2, which compare favorably to peers like Medtronic and Stryker Corp. while also demonstrating positive stock performance relative to the Sensex.

Score

Click here to find our call on this stock

Strong Sell

Sell

Hold

Buy

Strong Buy

MarketsMojo — Loved in India, Now Global

The power of Mojo is now in 29 countries. Explore global equities with the same cutting-edge features you love.Unlock 29 Markets

Dashboard

Poor Management Efficiency with a low ROE of 0%

The company has reported losses. Due to this company has reported negative ROE

Flat results in Mar 25

Risky - Negative EBITDA

Falling Participation by Institutional Investors

Consistent Underperformance against the benchmark over the last 3 years

Mojo Parameters

Stock DNA

Industry

Pharmaceuticals & Biotechnology

Market cap

USD 1 Million (Micro Cap)

P/E

NA (Loss Making)

Industry P/E

Dividend Yield

0.00%

Debt Equity

0.25

Return on Equity

-23.53%

Price to Book

0.08

Revenue and Profits:

Net Sales:

6 Million

(Quarterly Results - Mar 2025)

Net Profit:

-1 Million

Total Returns

Total Returns (Price + Dividend)

TimePeriod

Price Return

Dividend Return

Total Return

3 Months

-49.33%

6 Months

-50.65%

1 Year

-69.22%

2 Years

-92.43%

3 Years

-97.92%

4 Years

-99.14%

5 Years

-98.83%

Dynatronics Corp. for the last several years.

Risk Adjusted Returns v/s

News & Corporate Actions

News

No Recent News for the Company

Announcements

No announcement available

Corporate Actions

No corporate action available

Key Factors

Quality key factors

Factor

Value

Sales Growth (5y)

-14.10%

EBIT Growth (5y)

-197.48%

EBIT to Interest (avg)

-3.73

Debt to EBITDA (avg)

Negative Net Debt

Net Debt to Equity (avg)

0.25

Sales to Capital Employed (avg)

1.93

Tax Ratio

0.43%

Dividend Payout Ratio

Pledged Shares

Institutional Holding

3.32%

ROCE (avg)

ROE (avg)

Valuation key factors

Factor

Value

P/E Ratio

NA (Loss Making)

Industry P/E

Price to Book Value

0.07

EV to EBIT

-1.60

EV to EBITDA

-3.06

EV to Capital Employed

0.26

EV to Sales

0.14

PEG Ratio

Dividend Yield

ROCE (Latest)

-16.11%

ROE (Latest)

-23.53%

Technicals key factors

Indicator

Weekly

Monthly

MACD

Mildly Bullish

RSI

No Signal

Bollinger Bands

Mildly Bearish

Moving Averages

Mildly Bearish (Daily)

KST

Bearish

Mildly Bullish

Dow Theory

No Trend

OBV

No Trend

Mildly Bearish

Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned

Shareholding

Shareholding Snapshot : Mar 2025

Shareholding Compare (%holding)

Majority shareholders

Domestic Funds

Held in 2 Schemes (0.23%)

Foreign Institutions

Held by 0 Foreign Institutions (0%)

Strategic Entities with highest holding

Highest Public shareholder

Financial

[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Consolidated) - Mar'25 - QoQ",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "QoQ Growth in quarter ended Mar 2025 is -15.07% vs -3.95% in Dec 2024",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "QoQ Growth in quarter ended Mar 2025 is -25.00% vs -100.00% in Dec 2024",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Mar'25",
        "Dec'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "6.20",
          "val2": "7.30",
          "chgp": "-15.07%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "-0.70",
          "val2": "-0.40",
          "chgp": "-75.00%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "0.10",
          "val2": "0.10",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "-1.00",
          "val2": "-0.80",
          "chgp": "-25.00%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "-153.50%",
          "val2": "-91.30%",
          "chgp": "-6.22%",
          "chgp_class": "negative"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Jun'24",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Jun 2024 is -19.95% vs -8.35% in Jun 2023",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Jun 2024 is 46.00% vs -25.00% in Jun 2023",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Jun'24",
        "Jun'23",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "32.50",
          "val2": "40.60",
          "chgp": "-19.95%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "-1.00",
          "val2": "-3.50",
          "chgp": "71.43%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "0.40",
          "val2": "0.10",
          "chgp": "300.00%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "-2.70",
          "val2": "-5.00",
          "chgp": "46.00%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "-69.90%",
          "val2": "-119.50%",
          "chgp": "4.96%",
          "chgp_class": "positive"
        }
      ]
    }
  }
]

Quarterly Results Snapshot (Consolidated) - Mar'25 - QoQ

Mar'25

Dec'24

Change(%)

Net Sales

6.20

7.30

-15.07%

Operating Profit (PBDIT) excl Other Income

-0.70

-0.40

-75.00%

Interest

0.10

Exceptional Items

0.00

Consolidate Net Profit

-1.00

-0.80

-25.00%

Operating Profit Margin (Excl OI)

-153.50%

-91.30%

-6.22%

USD in Million.

Compare with Peers

Net Sales

QoQ Growth in quarter ended Mar 2025 is -15.07% vs -3.95% in Dec 2024

Consolidated Net Profit

QoQ Growth in quarter ended Mar 2025 is -25.00% vs -100.00% in Dec 2024

All Quarterly Results

Annual Results Snapshot (Consolidated) - Jun'24

Jun'24

Jun'23

Change(%)

Net Sales

32.50

40.60

-19.95%

Operating Profit (PBDIT) excl Other Income

-1.00

-3.50

71.43%

Interest

0.40

0.10

300.00%

Exceptional Items

0.00

Consolidate Net Profit

-2.70

-5.00

46.00%

Operating Profit Margin (Excl OI)

-69.90%

-119.50%

4.96%

USD in Million.

Compare with Peers

Net Sales

YoY Growth in year ended Jun 2024 is -19.95% vs -8.35% in Jun 2023

Consolidated Net Profit

YoY Growth in year ended Jun 2024 is 46.00% vs -25.00% in Jun 2023

All Annual Results

Company CV

About Dynatronics Corp.

Dynatronics Corp.

Pharmaceuticals & Biotechnology

Dynatronics Corporation is a manufacturer and distributor of physical medicine products. The Company's products include a line of medical equipment for physical medicine applications, including therapy devices, medical supplies and soft goods, treatment tables and rehabilitation equipment. Its products are used by physical therapists, chiropractors, sports medicine practitioners, podiatrists, physicians and other physical medicine professionals. Its physical medicine products include therapeutic modalities, such as Dynatron Solaris, including electrotherapy and thermal therapy, and 25 Series, including electrotherapy and ultrasound; manufactured capital products, including traction systems and wood furniture; manufactured supplies, including cold packs, straps, wedges, bolsters and mats; distributed capital products, including hydrotherapy, weight training equipment and pilates, and distributed supplies, including clinical accessories, sports med and taping products, lotions and gels.

Company Coordinates

Company Details

7030 S Park Centre Dr Bldg D , SALT LAKE CITY UT : 84121-6618

Tel: 1 801 5687000

https://www.dynatronics.com

Registrar Details

Dynatronics Corp.

1Day

52 Week

CASH

FII

DII

Promoter

What does Dynatronics Corp. do?

Watch in Real-Time

Who are in the management team of Dynatronics Corp.?

Is Dynatronics Corp. technically bullish or bearish?

Is Dynatronics Corp. overvalued or undervalued?

MarketsMojo — Loved in India, Now Global

Dashboard

Poor Management Efficiency with a low ROE of 0%

Flat results in Mar 25

Risky - Negative EBITDA

Falling Participation by Institutional Investors

Consistent Underperformance against the benchmark over the last 3 years

Mojo Parameters

Stock DNA

Total Returns (Price + Dividend)

Risk Adjusted Returns v/s

News

Announcements

Corporate Actions

Quality key factors

Valuation key factors

Technicals key factors

Shareholding Snapshot : Mar 2025

Shareholding Compare (%holding)

Quarterly Results Snapshot (Consolidated) - Mar'25 - QoQ

Annual Results Snapshot (Consolidated) - Jun'24

About Dynatronics Corp.

Company Coordinates